X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (80) 80
humans (76) 76
hematology (58) 58
abridged index medicus (27) 27
male (24) 24
female (23) 23
peripheral vascular disease (23) 23
anticoagulants (21) 21
heparin - adverse effects (21) 21
middle aged (17) 17
heparin-induced thrombocytopenia (16) 16
thrombocytopenia - chemically induced (16) 16
anticoagulants - adverse effects (15) 15
article (15) 15
heparin (15) 15
thrombocytopenia - diagnosis (15) 15
anticoagulants - therapeutic use (14) 14
adult (13) 13
diagnosis (13) 13
hit (13) 13
thrombocytopenia (13) 13
management (12) 12
thrombosis (12) 12
molecular-weight heparin (11) 11
rivaroxaban (11) 11
aged (10) 10
dabigatran (10) 10
hemophilia (10) 10
platelet count (10) 10
thromboembolism (10) 10
apixaban (9) 9
atrial fibrillation (9) 9
cardiology (9) 9
administration, oral (8) 8
anti-pf4/heparin antibodies (8) 8
bleeding (8) 8
cardiac & cardiovascular systems (8) 8
patients (8) 8
platelet factor 4 - immunology (8) 8
prothrombin complex concentrate (8) 8
unfractionated heparin (8) 8
warfarin (8) 8
analysis (7) 7
care and treatment (7) 7
deep-vein thrombosis (7) 7
medical colleges (7) 7
partial thromboplastin time (7) 7
purpura, thrombocytopenic, idiopathic - drug therapy (7) 7
risk factors (7) 7
rituximab (7) 7
thrombocytopenia - immunology (7) 7
antithrombotic therapy (6) 6
atrial-fibrillation (6) 6
blood platelets (6) 6
cardiopulmonary bypass (6) 6
edoxaban (6) 6
efficacy (6) 6
epidemiology (6) 6
fibrin (6) 6
heparin - immunology (6) 6
immune thrombocytopenia (6) 6
in-vitro (6) 6
international normalized ratio (6) 6
medicine & public health (6) 6
medicine, general & internal (6) 6
purpura (6) 6
research (6) 6
risk (6) 6
thrombin (6) 6
venous thromboembolism (6) 6
animals (5) 5
antibodies (5) 5
anticoagulants - administration & dosage (5) 5
cohort studies (5) 5
enzyme-linked immunosorbent assay (5) 5
factor xa inhibitor (5) 5
factor-xa inhibitor (5) 5
immunoassay (5) 5
platelets (5) 5
prospective studies (5) 5
pulmonary embolism (5) 5
sensitivity and specificity (5) 5
surgery (5) 5
therapy (5) 5
thrombocytopenia - blood (5) 5
thrombocytopenia - epidemiology (5) 5
thrombocytopenia - therapy (5) 5
time factors (5) 5
activated factor-vii (4) 4
activation (4) 4
antithrombins - pharmacology (4) 4
atrial fibrillation - complications (4) 4
coagulation assays (4) 4
dabigatran etexilate (4) 4
decision making (4) 4
deep vein thrombosis (4) 4
direct oral anticoagulants (4) 4
direct thrombin inhibitor (4) 4
disease management (4) 4
double-blind (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 07/2017, Volume 43, Issue 5, pp. 447 - 448
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 11, pp. 1128 - 1139
Abstract Background Non–vitamin K oral anticoagulants (NOACs) do not require routine laboratory monitoring. However, laboratory measurement may be desirable in... 
Cardiovascular | Internal Medicine | dabigatran | rivaroxaban | monitoring | laboratory | apixaban | MEASURING RIVAROXABAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | DABIGATRAN CONCENTRATIONS | PROTHROMBIN TIME | PARTIAL THROMBOPLASTIN TIME | COAGULATION ASSAYS | IN-VITRO | FACTOR-XA INHIBITOR | PLASMA-CONCENTRATIONS | INTERNATIONAL NORMALIZED RATIO | Anticoagulants - administration & dosage | Humans | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Factor Xa Inhibitors - administration & dosage | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - pharmacology | Factor Xa Inhibitors - pharmacology | beta-Alanine - analogs & derivatives | Pyrazoles - pharmacology | Administration, Oral | Morpholines - administration & dosage | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Pyrazoles - administration & dosage | Partial Thromboplastin Time | Anticoagulants - pharmacology | Benzimidazoles - pharmacology | Drug Monitoring | Pyridones - pharmacology | Measurement | Anticoagulants (Medicine) | Vitamins | Studies | Anticoagulants | Plasma | Bibliographic literature | Laboratories | Drug therapy | Drug dosages | Bone surgery
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 09/2016, Volume 115, Issue 11, pp. 835 - 842
Summary The clinical course of heparin-induced thrombocytopenia (HIT) may be separated into five sequential phases: 1. suspected HIT, 2. acute HIT, 3. subacute... 
Theme Issue Article | Treatment | Management | Heparin-induced thrombocytopenia | treatment | VENOUS LIMB GANGRENE | RISK-FACTORS | SCORE | ANTI-PF4/HEPARIN ANTIBODIES | THROMBOSIS | CARDIOPULMONARY BYPASS | ARGATROBAN | BIVALIRUDIN | HIT | management | PLATELET TRANSFUSIONS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2018, Volume 93, Issue 6, pp. 816 - 823
In patients with immune thrombocytopenia who do not adequately respond to first‐line therapy, there is no clear consensus on which second‐line therapy to... 
DOSE RITUXIMAB | EFFICACY | PURPURA | ROMIPLOSTIM | ELTROMBOPAG | OPEN-LABEL | SPLENECTOMY | QUALITY-OF-LIFE | HEMATOLOGY | THROMBOPOIETIN-RECEPTOR AGONISTS | LONG-TERM TREATMENT | Thrombocytopenia | Care and treatment | Critical Review
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 23, pp. 2215 - 2227
Journal Article
Blood, ISSN 0006-4971, 02/2016, Volume 127, Issue 5, pp. 522 - 524
In this issue of Blood, Nagler et al present a systematic review and meta-analysis on the diagnostic accuracy of immunoassays for heparin-induced... 
DIAGNOSIS | HEPARIN-INDUCED THROMBOCYTOPENIA | METAANALYSIS | HEMATOLOGY | 4TS SCORE | Immunoassay - methods | Thrombocytopenia - diagnosis | Thrombocytopenia - chemically induced | Anticoagulants - adverse effects | Heparin - adverse effects | Humans
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 11/2019, Volume 94, Issue 11, pp. 2161 - 2163
Journal Article
Seminars in Hematology, ISSN 0037-1963, 2010, Volume 47, Issue 3, pp. 289 - 298
Journal Article